A Phase 3, Open-label, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Romosozumab Compared with Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta

  • Brown, Justin (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date18/01/24 → 17/01/29

Clinical Trial Phase

  • Phase III (a & b)